Applications for this meeting must be submitted by May 18, 2014. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
The Lipoprotein Metabolism Gordon Research Conference will be held in conjunction with the Lipoprotein Metabolism Gordon Research Seminar
. Those interested in attending both meetings must submit an application for the GRS in addition to an application for the GRC. Please refer to the Lipoprotein Metabolism GRS web page for more information.
The Gordon Research Conference on Lipoprotein Metabolism is one of the longest standing conferences in the 80-year history of the GRC. The scientific content of our conference has continually evolved since the first meeting and, traditionally, is considered the preeminent forum in our discipline for the presentation of high impact leading edge science. The program for the 2014 Conference on Lipoprotein Metabolism will communicate new and exciting advances in the field and will bring together a range of established investigators, new investigators, and trainees from around the world to present and discuss a spectrum of topics related to new developments in lipid and lipoprotein metabolism, particularly in those areas that impact upon human disease. Basic molecular and cell biological studies, animal models of metabolism, and genetic studies in humans will be presented. Topics include lipases, hepatic and intestinal lipid metabolism, HDL and reverse cholesterol transport, lipoprotein receptors and the vascular wall, CNS lipid metabolism, intracellular lipid metabolism and lipid droplets, genetics of lipid and lipoprotein metabolism, and therapeutics of lipid and cardiovascular disease. In addition to outstanding leading-edge lectures and discussion, poster presentations represent an integral part of the scientific program. There will be a keynote speaker, and additional Oral Session presentations will be selected from among submitted abstracts.
A list of preliminary session topics and speakers is displayed below (discussion leaders, where known, are noted in italics). The detailed program is currently being developed by the Conference Chair and will be available by February 15, 2014. Please check back for updates.
(Rudolf Zechner / Rudolf Zechner / Perry Bickel / Jorge Plutzsky)
- Hepatic & Intestinal Lipid Metabolism
(Jay Horton / Jay Horton / Steve Kliewer / Carlos Fernandez-Hernando / Chih Hao Lee)
- HDL & Reverse Cholesterol Transport
(Peter Edwards / Tom Vallim / Mark Brown / Marina Cuchel)
- Lipoprotein Receptors and Vascular Wall
(Joachim Herz / Ira Tabas / Philipe Boucher / Phil Shaul / Andreas Niemeier)
- CNS & Lipids
(Cheryl Wellington / Cheryl Wellington / David Holtzman / Emily Osterweil)
- Intracellular Lipid Metabolism
(Tobias Walther / Tobias Walther / Peng Li / Anders Naar / Jin Ye)
- Genetics of Lipid and Lipoprotein Metabolism
(Dan Rader / Jake Lusis / Alan Shuldiner / Karen Reue)
- Therapeutics of Lipid and Cardiovascular Disease
(Shirly Pinto / Nancy Thornberry / Craig Hammond / Rosanne Crooke)
- Keynote Session: Lipid and Lipoprotein Metabolism